Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Clinical

  • 1
    News

    Short-course azithromycin no benefit in pediatric asthma admissions

    July 31, 2019

    SEATTLE – Clinicians should consider these data before prescribing azithromycin to children hospitalized with asthma.

  • 1
    Article

    Short Takes

    July 30, 2019

    In the Literature's Short Takes

  • 1
    News

    FDA approvals permit double-immunoassay approach to Lyme disease diagnosis

    July 29, 2019

    The streamlined approach to diagnosis may speed treatment of Lyme disease.

  • 1
    News

    Most patients with new hypertension under revised BP guidelines won’t need pharmacotherapy

    July 29, 2019

    ORLANDO – In terms of nonpharmacologic therapies for these patients, the largest benefit is in getting them to lose weight.

  • 1
    News

    Gram-negative bacteremia: Cultures, drugs, and duration

    July 29, 2019

    Management of gram-negative bacteremia remains a challenging clinical situation for inpatient providers.

  • News

    Beyond C. difficile: The future of fecal microbial transplantation

    July 29, 2019

    SAN DIEGO – Future directions for microbial transplantation range from multifactorial and functional gut disorders to consideration of the small intestinal microbiome.

  • 1
    News

    Older adults’ interested in conversations about deprescribing

    July 29, 2019

    Among older adults, what attitudes exist toward deprescribing?

  • 1
    News

    NSAID use in high-risk patients not linked with short-term, safety-related adverse event

    July 26, 2019

    In patients with hypertension, chronic kidney disease, or heart failure presenting with a musculoskeletal disorder, how frequently are prescription NSAIDs dispensed and are there associated short-term (between 7-38 days of visit) safety-related outcomes?

  • 1
    News

    Efficacy of DOACs vs. warfarin in high-risk atrial fibrillation patients

    July 25, 2019

    Are the direct-acting anticoagulants (DOACs) rivaroxaban and dabigatran efficacious and safe, compared with warfarin, in elderly atrial fibrillation patients with new-onset atrial fibrillation and multiple major comorbidities?

  • 1
    News

    FDA approves Baqsimi nasal powder for emergency hypoglycemia treatment

    July 25, 2019

    It is the first glucagon therapy approved for this indication that is administrable without an injection.

Previous1 … 198 199 200 201 202 … 402Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences